Inflammatory Bowel Disease
Key Points
- IBD encompasses two chronic autoimmune disorders: ulcerative colitis (UC) and Crohn’s disease (CD).
- UC affects only the mucosa/submucosa of the large intestine in a uniform pattern; CD can affect all GI tract layers anywhere from mouth to anus with skip lesions.
- Common manifestations include diarrhea, abdominal pain, weight loss, fever, and extraintestinal signs (joint, eye, skin).
- Treatment follows a stepwise approach: aminosalicylates → corticosteroids → immunomodulators/biologics → surgery.
- Both UC and CD are chronic, relapsing disorders associated with increased long-term GI cancer risk.
Pathophysiology
IBD involves chronic autoimmune-driven mucosal inflammation of the GI tract. The exact trigger is unknown but may involve normal intestinal bacteria, certain drugs or toxins, or infectious processes acting on a genetically susceptible host. Risk patterns include family history, age 15-30 or over 60, and higher prevalence in Northern European/Jewish ancestry, developed countries, and colder climates.
In UC, inflammation begins in the rectum and spreads uniformly upward through the colon, affecting only the mucosa and submucosa. The colon eventually becomes inflexible and shortened, losing its haustra folds. Ulcerations bleed, and stools often contain blood and mucus.
In CD, inflammation starts as singular lesions and deepens into full-thickness ulcerations. The hallmark is skip lesions — inflamed segments separated by normal bowel. The cobblestone appearance results from deep fissuring. Scar tissue leads to strictures and fistulas.
Both disorders carry an increased risk for GI tract cancer and cannot be cured medically.
Classification
| Feature | Ulcerative Colitis | Crohn’s Disease |
|---|---|---|
| Layers affected | Mucosa and submucosa only | All bowel layers (transmural) |
| Location | Large intestine only | Anywhere — mouth to anus |
| Lesion pattern | Uniform, continuous from rectum | Skip lesions with normal segments |
| Stool | Bloody diarrhea with mucus | Non-bloody diarrhea common |
| Pain location | Left upper or left lower quadrant | Right lower quadrant |
| Tenesmus | Common | Rare |
| Fistulas/strictures | Rare | Common complication |
| Weight loss | Rare | Common |
| Nausea/vomiting | Rare | Common |
Nursing Assessment
NCLEX Focus
Identify early signs of acute flare — bloody diarrhea, fever, tachycardia, and signs of dehydration — and escalate for fluid and electrolyte management.
- Assess stool character, frequency, and presence of blood or mucus.
- Assess for signs of dehydration: tachycardia, hypotension, dry mucous membranes, poor skin turgor.
- Assess for fever and markers of systemic infection.
- Assess nutritional status, weight trend, and albumin level.
- Assess for anal fistulas, abscesses, rectal prolapse (more common in CD).
- Assess for extraintestinal manifestations: joint pain, eye redness, skin rash, canker sores, and hepatobiliary involvement.
Diagnostics:
- CBC: anemia from blood loss, elevated WBC (inflammation), elevated platelets in CD (DVT/PE risk)
- Comprehensive metabolic panel: decreased albumin (malnutrition), electrolyte imbalances
- Inflammatory markers: elevated CRP and ESR
- Stool studies: fecal calprotectin elevation; rule out ova, parasites, and C. difficile
- Endoscopy with biopsy (commonly colonoscopy; EGD in selected cases): gold standard for confirming IBD
- Barium studies: support pattern recognition (UC “lead pipe” appearance vs CD skip lesions)
- Ultrasound, abdominal X-ray, CT, or MRI: assess for strictures, fistulas, perforation, and bowel obstruction
Nursing Interventions
- Monitor fluid and electrolyte balance closely during acute flares.
- Coordinate nutritional support — enteral nutrition or TPN may be needed in severe cases.
- Implement skin care and perianal protection when diarrhea is frequent.
- Encourage hydration (commonly about 2 L/day if not contraindicated) and track intake/output with stool burden.
- Encourage surveillance colonoscopy (about every 1-2 years in high-risk chronic disease) because colorectal cancer risk is increased.
- Educate on infection prevention and vaccine adherence — immunosuppressive therapy increases infection risk.
- Teach stress reduction strategies and trigger avoidance.
- Refer to mental health care and peer-support resources when anxiety or depression burden is high.
- Prepare and support patients undergoing colonoscopy or surgical procedures.
- Provide focused teaching: avoid nsaids, report medication adverse effects promptly, recognize perforation warning symptoms, and use individualized food triggers (often limiting dairy, caffeine, alcohol, and high-fat/high-fiber foods during flares while maintaining high-protein/high-calorie/vitamin intake).
Toxic Megacolon
Severe UC can progress to toxic megacolon — non-obstructive colonic dilation with systemic toxicity. Assess for abdominal distension, fever, and tachycardia. This is a surgical emergency.
Perforation Or Obstruction
Escalate urgently for worsening abdominal pain/distension, fever, tachycardia, hypotension, or peritoneal signs that may indicate perforation, obstruction, or peritonitis.
Pharmacology
Medication therapy follows a stepwise approach:
| Step | Drug Class | Examples | Key Nursing Points |
|---|---|---|---|
| Step 1 | Aminosalicylates | Mesalamine | Anti-inflammatory; used for mild-moderate UC |
| Step 2 | Corticosteroids | Prednisone, budesonide | For flares; taper to prevent adrenal suppression |
| Step 3 | Immunomodulators / Biologics | Azathioprine, infliximab (anti-TNF-α) | Increased infection risk; monitor CBC and LFTs |
| Step 4 | Disease-specific agents | Vedolizumab (UC), ustekinumab (CD) | Experimental; significant side effects |
Probiotics and antidiarrheals may supplement therapy for mild symptom management.
For severe or high-risk disease, a step-down strategy may be used: start with potent therapy first, then de-escalate after symptom control.
Surgical Considerations
- UC: Total colectomy with stoma may be required when medications fail or complications occur. It can resolve intestinal UC disease but does not cure extraintestinal manifestations.
- CD: Surgery is complication-directed (for example strictures, fistulas, or severe localized disease) and is not a definitive cure.
Clinical Judgment Application
Clinical Scenario
A patient with known UC presents with 10 bloody diarrhea episodes per day, fever 38.9°C (102°F), heart rate 112, and abdominal distension.
- Recognize Cues: High-frequency bloody diarrhea, fever, tachycardia, and distension in a patient with UC.
- Analyze Cues: Signs of severe flare with possible progression toward toxic megacolon.
- Prioritize Hypotheses: Fluid/electrolyte imbalance and infection risk are immediate concerns.
- Generate Solutions: IV fluid resuscitation, NPO, IV corticosteroids, stool cultures, and surgical consult.
- Take Action: Implement interventions, monitor vital signs closely, and escalate rapidly if distension worsens.
- Evaluate Outcomes: Decreased stool frequency, resolution of fever, hemodynamic stability.
Related Concepts
- digestive-system — Anatomy of the GI tract layers and immune function underlying IBD.
- diarrhea-assessment-and-management — Assessment and management of diarrhea in IBD flares.
- disease-modifying-antirheumatic-drugs — Immunomodulators share mechanisms with DMARD therapy.
- biologic-response-modifiers — Anti-TNF biologics are central to step-3 IBD management.
- clostridioides-difficile-infection — C. diff must be ruled out in IBD flares with diarrhea.
- nutritional-assessment-framework — Malnutrition assessment and support in IBD.
Self-Check
- What are the key differences between Crohn’s disease and ulcerative colitis in lesion pattern and bowel layer involvement?
- Why are patients on biological therapy for IBD at increased risk for infection?
- Which clinical findings should prompt the nurse to suspect toxic megacolon?